Guided Therapeutics (GTHP) Return on Capital Employed Growth (3y) (2015 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1,962.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 214.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 31.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 355.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -846.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,318.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -247.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 362.00
10 Guided Therapeutics - - 458,000.00 -22,350.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -22,350.00
Sep 30, 2025 -7,506.00
Jun 30, 2025 -826.00
Mar 31, 2025 -1,196.00
Dec 31, 2024 -1,709.00
Sep 30, 2024 -2,496.00
Jun 30, 2024 -412.00
Mar 31, 2024 5,688.00
Dec 31, 2023 10,006.00
Sep 30, 2023 13,107.00
Jun 30, 2023 18,308.00
Mar 31, 2023 41,609.00
Dec 31, 2022 25,841.00
Sep 30, 2022 10,386.00
Jun 30, 2022 3,905.00
Mar 31, 2022 4,516.00
Dec 31, 2021 4,607.00
Sep 30, 2021 5,015.00
Jun 30, 2021 2,850.00
Mar 31, 2021 -326.00
Dec 31, 2020 -1,408.00
Sep 30, 2020 -2,135.00
Jun 30, 2020 -1,851.00
Mar 31, 2020 -2,815.00
Dec 31, 2019 -4,249.00
Sep 30, 2019 -5,604.00
Jun 30, 2019 -8,519.00
Mar 31, 2019 -15,767.00
Dec 31, 2018 -21,407.00
Sep 30, 2018 -43,536.00
Jun 30, 2018 -48,881.00
Mar 31, 2018 -31,555.00
Dec 31, 2017 -67,904.00
Sep 30, 2017 -222,102.00
Jun 30, 2017 105,013.00
Mar 31, 2017 351,355.00
Dec 31, 2016 53,932.00
Sep 30, 2016 37,975.00
Jun 30, 2016 33,898.00
Mar 31, 2016 42,936.00
Dec 31, 2015 46,923.00
Sep 30, 2015 85,370.00
Jun 30, 2015 397,812.00
Mar 31, 2015 80,212.00